Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul;14(7):1271-1280.
doi: 10.1111/os.13254. Epub 2022 Apr 29.

Treatment of Intervertebral Disc Degeneration

Affiliations
Review

Treatment of Intervertebral Disc Degeneration

Jingguo Xin et al. Orthop Surg. 2022 Jul.

Abstract

Intervertebral disc degeneration (IDD) causes a variety of signs and symptoms, such as low back pain (LBP), intervertebral disc herniation, and spinal stenosis, which contribute to high social and economic costs. IDD results from many factors, including genetic factors, aging, mechanical injury, malnutrition, and so on. The pathological changes of IDD are mainly composed of the senescence and apoptosis of nucleus pulposus cells (NPCs), the progressive degeneration of extracellular matrix (ECM), the fibrosis of annulus fibrosus (AF), and the inflammatory response. At present, IDD can be treated by conservative treatment and surgical treatment based on patients' symptoms. However, all of these can only release the pain but cannot reverse IDD and reconstruct the mechanical function of the spine. The latest research is moving towards the field of biotherapy. Mesenchymal stem cells (MSCs) are regard as the potential therapy of IDD because of their ability to self-renew and differentiate into a variety of tissues. Moreover, the non-coding RNAs (ncRNAs) are found to regulate many vital processes in IDD. There have been many successes in the in vitro and animal studies of using biotherapy to treat IDD, but how to transform the experimental data to real therapy which can apply to humans is still a challenge. This article mainly reviews the treatment strategies and research progress of IDD and indicates that there are many problems that need to be solved if the new biotherapy is to be applied to clinical treatment of IDD. This will provide reference and guidance for clinical treatment and research direction of IDD.

Keywords: Conservative treatment; Intervertebral disc degeneration; Mesenchymal stem cells; Non-coding rna; Surgical treatment.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that there are no competing interests.

Figures

Fig. 1
Fig. 1
(A) The intervertebral discs firmly connect the upper and lower vertebrae and decompress, absorb shocks, and increase the range of spinal movement. (B) Three elements of intervertebral disc and adjacent structure. (C) Annulus fibrosus broke and nucleus pulposus herniate at the posterior part where near the spine canal.

References

    1. James SL, Abate D, Abate KH, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990‐2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392:1789–858. - PMC - PubMed
    1. Wu A, March L, Zheng X, et al. Global low back pain prevalence and years lived with disability from 1990 to 2017: estimates from the global burden of disease study 2017. Ann Transl Med. 2020;8:299. - PMC - PubMed
    1. Maher C, Underwood M, Buchbinder R. Non‐specific low back pain. Lancet. 2017;389:736–47. - PubMed
    1. Vlaeyen JWS, Maher CG, Wiech K, et al. Low back pain. Nat Rev Dis Primers. 2018;4:52. - PubMed
    1. Le Maitre CL, Freemont AJ, Hoyland JA. Accelerated cellular senescence in degenerate intervertebral discs: a possible role in the pathogenesis of intervertebral disc degeneration. Arthritis Res Ther. 2007;9:R45. - PMC - PubMed

MeSH terms